Oxford Stemtech LTD

England

UEI
GVC6GTVGN587
CAGE
U29E4
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
71-75 Shelton St, London WC2H 9JQ, UK
Founded
2020
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $493,244
FY2025 $0
FY2024 $313,851

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Health and Human Services $493,244

Contract awards

Similar vendors

About the company

Oxford Stemtech LTD, a United Kingdom-based for-profit corporation headquartered in London, supplies induced pluripotent stem cell (iPSC) generation, characterization, and multiomics profiling services to the National Institutes of Health (NIH) as a prime contractor on small-dollar purchase orders. The vendor operates exclusively in a full-and-open posture with no small-business set-aside designations across its recent federal footprint. Oxford Stemtech holds proprietary expertise in iPSC pipeline processing that has driven sole-source selections from federal research agencies, particularly around iPSC-derived cellular models and organoid generation.

The vendor's customer concentration is highly concentrated within a single NIH component. The National Institute of Mental Health accounts for three awards totaling $623 thousand (77% of combined potential value across all awards), with the National Institute on Drug Abuse holding one award for $184 thousand, representing the full $807 thousand in recent federal contract activity. Both customers fall under the Department of Health and Human Services. Recent capability work includes a $248,747 firm fixed-price purchase order from NIMH for non-severable scientific support services (award date August 6, 2026, ultimate completion August 5, 2027), a $244,497 purchase order for diagnostic laboratory services supporting organoid generation and characterization (award date September 24, 2026, ultimate completion May 23, 2027), a $130,120 sole-source purchase order from NIMH for iPSC-derived collaborative research services (award date September 16, 2024, ultimate completion March 15, 2026), and a $183,731 firm fixed-price purchase order from the National Institute on Drug Abuse for iPSC-derived neuronal model generation and multiomics profiling (award date September 11, 2024, ultimate completion September 10, 2025).

Activity remains nascent with two awards each in 2024 and 2026. Within the next twenty-four months, two awards with combined potential value of $493 thousand face ultimate completion and therefore recompete exposure. The vendor has not occupied parent contract vehicles, IDVs, BPAs, or GWACs; all work flows through direct purchase orders. Primary NAICS categories are Other Scientific and Technical Consulting Services and Research and Development in Biotechnology, with work performed in Great Britain, United Kingdom, and Bethesda, Maryland.

Quick answers

Is Oxford Stemtech LTD registered in SAM.gov?

Yes. Oxford Stemtech LTD's SAM.gov registration is active through September 5, 2027.

What is Oxford Stemtech LTD's CAGE code?

Oxford Stemtech LTD's CAGE code is U29E4, and its Unique Entity ID (UEI) is GVC6GTVGN587.

How much has Oxford Stemtech LTD received in federal contracts?

Federal contracts obligated $807,095 to Oxford Stemtech LTD in fiscal years 2023 through 2027.

What is Oxford Stemtech LTD's most recent federal award?

Oxford Stemtech LTD's most recent federal contract award is Nimh: supply: diagnostic laboratory services: N/a (75N95B26P00036), from National Institute of Mental Health (NIH), on September 24, 2026.

On GovTribe

See Oxford Stemtech LTD's full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe